Medicare Enrolled

Dr. Kimberly Portch, PA-C

Physician Assistant · Spokane Valley, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
13424 E MISSION AVE, Spokane Valley, WA 99216
5098224200
In practice since 2020 (6 years)
NPI: 1164058277 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Portch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Portch? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Portch

Dr. Kimberly Portch is a physician assistant in Spokane Valley, WA, with 6 years of NPI registration. Based on federal Medicare data, Dr. Portch performed 1,984 Medicare services across 238 unique beneficiaries.

Between the years covered by Open Payments, Dr. Portch received a total of $13,151 from 80 pharmaceutical and/or device companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Portch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice ▲ Top 5% volume in WA $13,151 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,984
Medicare services
Top 5% in WA for physician assistant
238
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~331 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,740 $18 $64
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
54 $50 $277
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
48 $7 $29
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
43 $10 $39
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
41 $8 $9
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
23 $9 $67
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
19 $79 $421
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $81 $390
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
88.9% medium
10.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,151
Total received (2021-2024)
Avg $3,288/year across 4 years
Top 1% in WA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
586
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,925 (90.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,226 (9.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,686
2023
$4,551
2022
$4,167
2021
$747

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$310
Janssen Biotech, Inc.
$281
PFIZER INC.
$264
Celgene Corporation
$260
Genentech USA, Inc.
$224
E.R. Squibb & Sons, L.L.C.
$192
AstraZeneca Pharmaceuticals LP
$178
ABBVIE INC.
$160
EMD Serono, Inc.
$158
Merck Sharp & Dohme LLC
$140
GENZYME CORPORATION
$134
Regeneron Healthcare Solutions, Inc.
$119
Lilly USA, LLC
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
Incyte Corporation
$64
Eisai Inc.
$64
ARRAY BIOPHARMA INC
$63
GlaxoSmithKline, LLC.
$60
Takeda Pharmaceuticals U.S.A., Inc.
$59
Bayer Healthcare Pharmaceuticals Inc.
$55
ACCORD HEALTHCARE, INC.
$54
Fresenius Kabi USA, LLC
$53
Astellas Pharma US Inc
$51
SpringWorks Therapeutics, Inc.
$48
Acrotech Biopharma Inc.
$47
Exelixis Inc.
$45
SOBI, INC
$35
Immunocore Limited
$33
Deciphera Pharmaceuticals Inc.
$32
Gilead Sciences, Inc.
$31
Rigel Pharmaceuticals, Inc.
$31
Alnylam Pharmaceuticals Inc.
$31
TerSera Therapeutics LLC
$30
Blueprint Medicines Corporation
$30
BeiGene USA, Inc.
$29
PROGENICS PHARMACEUTICALS, INC.
$28
PUMA BIOTECHNOLOGY, INC.
$27
Daiichi Sankyo Inc.
$26
Stemline Therapeutics Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
SERVIER PHARMACEUTICALS LLC
$18
Myriad Genetic Laboratories, Inc.
$16
Pharming Healthcare, Inc.
$16
Top 3 companies account for 23.2% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$1,416
Celgene Corporation
$775
Novartis Pharmaceuticals Corporation
$747
PFIZER INC.
$726
E.R. Squibb & Sons, L.L.C.
$710
Genentech USA, Inc.
$563
Seagen Inc.
$529
Incyte Corporation
$494
Merck Sharp & Dohme LLC
$437
Takeda Pharmaceuticals U.S.A., Inc.
$419
ABBVIE INC.
$352
GENZYME CORPORATION
$325
Lilly USA, LLC
$306
Astellas Pharma US Inc
$298
AstraZeneca Pharmaceuticals LP
$291
Amgen Inc.
$268
Eisai Inc.
$257
Regeneron Healthcare Solutions, Inc.
$241
EMD Serono, Inc.
$224
GlaxoSmithKline, LLC.
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$194
Blueprint Medicines Corporation
$163
AVEO Pharmaceuticals, Inc.
$141
BeiGene USA, Inc.
$131
TerSera Therapeutics LLC
$126
PharmaEssentia USA Corporation
$123
Pharmacyclics LLC, An AbbVie Company
$123
EISAI INC.
$119
ARRAY BIOPHARMA INC
$118
Janssen Scientific Affairs, LLC
$112
SANOFI-AVENTIS U.S. LLC
$110
Exelixis Inc.
$92
MorphoSys, US Inc.
$91
Gilead Sciences, Inc.
$90
JAZZ PHARMACEUTICALS INC.
$90
Alnylam Pharmaceuticals Inc.
$88
Deciphera Pharmaceuticals Inc.
$85
SERVIER PHARMACEUTICALS LLC
$83
Stemline Therapeutics Inc.
$80
Pharmacosmos Therapeutics Inc.
$80
Bayer Healthcare Pharmaceuticals Inc.
$74
Immunocore Limited
$66
G1 Therapeutics, Inc.
$61
Rigel Pharmaceuticals, Inc.
$60
Sobi, Inc
$54
ACCORD HEALTHCARE, INC.
$54
Fresenius Kabi USA, LLC
$53
MACROGENICS, INC.
$53
SpringWorks Therapeutics, Inc.
$48
Acrotech Biopharma Inc.
$47
Kite Pharma, Inc.
$46
Epizyme, Inc.,
$44
Agios Pharmaceuticals, Inc.
$44
Foundation Medicine, Inc.
$36
SOBI, INC
$35
Myriad Genetic Laboratories, Inc.
$32
Stryker Corporation
$31
Dendreon Pharmaceuticals LLC
$29
PROGENICS PHARMACEUTICALS, INC.
$28
PUMA BIOTECHNOLOGY, INC.
$27
Daiichi Sankyo Inc.
$26
Sun Pharmaceutical Industries Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
CTI BioPharma Corp.
$24
AbbVie Inc.
$24
Acceleron Pharma, Inc.
$24
Puma Biotechnology, Inc.
$23
Taiho Oncology, Inc.
$23
Heron Therapeutics, Inc.
$23
Adaptive Biotechnologies Corporation
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Servier Pharmaceuticals LLC
$20
Mirati Therapeutics, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
ADC Therapeutics America, Inc.
$19
AMAG Pharmaceuticals, Inc.
$18
EUSA Pharma (US) LLC
$16
Pharming Healthcare, Inc.
$16
Coherus Biosciences Inc.
$14
Acrotech Biopharma LLC
$11
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CAMCEVI · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DOPTELET · ENHERTU · EPKINLY · ERLEADA · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXLUMO · Odomzo · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · REZUROCK · RUCONEST · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SPY-PHI SYSTEM · SUSTOL · Stimufend · Stivarga · Sylvant · TABRECTA · TALVEY · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Vonjo · XALKORI · XOSPATA · XTANDI · Xermelo · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for physician assistant in WA.

Looking for a physician assistant in Spokane Valley?
Compare physician assistants in the Spokane Valley area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
364
Per 100K population
66.9
County median income
$73,513
Nearest hospital
MULTICARE VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Portch is a mixed practice specialist, with above-average Medicare volume (top 5% in WA), with low-engagement industry engagement in the top 1% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Portch experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Portch performed 1,740 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Portch receive payments from pharmaceutical companies?
Yes. Dr. Portch received a total of $13,151 from 80 companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Portch's costs compare to other physician assistants in Spokane Valley?
Dr. Portch's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Portch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →